DG
Daniil Gataulin Chardan Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
68
Avg Return
Past Year
Past Year
18%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
88.2%
Neutral
11.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $1 |
83%
upside
| 1 | – |
–
| 5 Jan ‘26 14 days ago |
|
|
|
Buy
Initiated
| $16 |
164%
upside
| 1 | +17% |
0
%
| 23 Dec ‘25 27 days ago |
|
|
|
Buy
Initiated
| $19 |
95%
upside
| 1 | -3.2% |
0
%
| 23 Dec ‘25 27 days ago |
|
|
|
Buy
Maintained
| $21 |
86%
upside
| 2 | +0.67% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $53 |
132%
upside
| 3 | +18% |
0
%
| 4 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $52 |
282%
upside
| 1 | +14% |
0
%
| 20 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $61 |
83%
upside
| 1 | +54% |
0
%
| 17 Nov ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $14 |
48%
downside
| 1 | – |
–
| 17 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $10 |
108%
upside
| 1 | +43% |
0
%
| 14 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $35 |
372%
upside
| 2 | +4.3% |
0
%
| 14 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $9 |
329%
upside
| 2 | +1.8% |
0
%
| 13 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $51 |
102%
upside
| 1 | +6.6% |
0
%
| 11 Nov ‘25 2 months ago |
|